The efficacy and safety of peripheral intravenous parenteral nutrition vs 10% glucose in preterm infants born 30 to 33 weeks’ gestation: a randomised controlled trial

Table 3 Clinical outcomes

Outcome	P-PN (n = 42)	Control (n = 50)	Adjusted effect^a (95% CI)	Adjusted P value^a
Days of feeding intolerance, mean, SD, d^b	0.6 (1.2)	0.6 (1.0)	1.0 (0.5, 2.1)^c	1.0
Days to full enteral feeds (120 mLs/kg/d), mean, SD, d	6.6 (2.4)	6.2 (1.7)	1.1 (0.9, 1.2)^c	0.3
Hypoglycemia requiring treatment	4.0 (9.5)	8.0 (16.0)	0.5 (0.1, 2.0)^d	0.4
IPPV via endotracheal tube	3.0 (7.1)	4.0 (8.0)	1.1 (0.2, 5.9)^d	0.9
Nasal CPAP	26.0 (61.9)	37.0 (74.0)	0.6 (0.2, 1.5)^d	0.3
Days of any respiratory support, mean, SD, d	4.2 (7.0)	5.3 (12.0)	0.8 (0.4, 1.5)^c	0.5
Confirmed sepsis^e	2 (4.8)	1 (2.0)	2.1 (0.2, 19.0)^d	0.5
Breastmilk (any) on discharge home (n = 38/46)	33 (87)	41 (89)	0.8 (0.2, 3.3)^d	0.8
Length of hospital stay, mean, SD, d	35.5 (10.5)	35.6 (13.8)	1.0 (0.9, 1.1)^c	0.8

Data are presented as n (%) unless otherwise indicated
^a Adjusted for sex and gestational age 30^+ 0 to 31^+ 6 and 32^+ 0 to 33^+ 6 weeks
^b Number of days on which one or more feeds were stopped
^c Adjusted ratio of means
^d Adjusted odds ratio
^e P-PN group rhinovirus n = 1, central line sepsis n = 1; Control group rhinovirus n = 1

ISSN: 1471-2431